CardioMetabolic medicine: the advent of systems cardiology and the new cardiovascular generalist?
Cardiometabolic medicine integrates organ dysfunction in the pancreas, kidney, liver, and the heart leading to a high risk of heart failure with preserved or reduced ejection fraction, myocardial infarction, stroke, and pre-mature death. In a recent article, published in the European Heart Journal, Prof. Thomas F. Lüscher, shares his perspective on how his novel specialty requires generalized training across several specialties to provide optimal care to an increasing number of patients.
Read the full article here
Florian Wenzl